Clinical Trial Update: Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial of SHP647 as induction therapy in moderate to severe ulcerative colitis was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SHP647

Snippet

Sponsor: Shire | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED | Results posted: 2021-05-07